{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:33:47Z","timestamp":1794332027428,"version":"4.9.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-01293"],"award-info":[{"award-number":["2021-01293"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["2021.027"],"award-info":[{"award-number":["2021.027"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jhep.2023.04.036","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T20:40:35Z","timestamp":1683664835000},"page":"842-852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":778,"title":["Changing epidemiology, global trends and implications for outcomes of NAFLD"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-9410","authenticated-orcid":false,"given":"Vincent Wai-Sun","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5590-8601","authenticated-orcid":false,"given":"Mattias","family":"Ekstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-9389","authenticated-orcid":false,"given":"Grace Lai-Hung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jhep.2023.04.036_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing\u00a0global epidemiology of liver cancer from 2010 to 2019: NASH is\u00a0the\u00a0fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2023.04.036_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib4","article-title":"Nash up, virus down: how the waiting list is changing for liver transplantation: a single center experience from Italy","volume":"58","author":"Ferrarese","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"10.1016\/j.jhep.2023.04.036_bib5","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.13751","article-title":"Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries","volume":"38","author":"Holmer","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.04.036_bib6","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/liv.14638","article-title":"Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.04.036_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-019-1171-x","article-title":"Rising rural body-mass index is the main driver of the global obesity epidemic in adults","volume":"569","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.04.036_bib8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cgh.2020.08.012","article-title":"Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population","volume":"19","author":"Wang","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/hep.32476","article-title":"Risk of\u00a0liver-related events by age and diabetes duration in patients with diabetes\u00a0and nonalcoholic fatty liver disease","volume":"76","author":"Zhang","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.036_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.32633","article-title":"Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease","volume":"77","author":"Lin","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/gutjnl-2016-313622","article-title":"High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national,\u00a0population-based cohort study in 1.2 million men","volume":"67","author":"Hagstrom","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.04.036_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhep.2016.03.019","article-title":"Overweight in late adolescence predicts development of severe liver disease later in life: a 39years follow-up study","volume":"65","author":"Hagstrom","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/apt.15162","article-title":"Body mass index in early pregnancy and future risk of severe liver disease: a population-based cohort study","volume":"49","author":"Hagstr\u00f6m","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.04.036_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2013.09.015","article-title":"Body mass index in childhood and adult risk of primary liver cancer","volume":"60","author":"Berentzen","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib16","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/hep.32228","article-title":"Global burden of NAFLD and chronic liver disease among adolescents and young adults","volume":"75","author":"Paik","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2017.03.029","article-title":"Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents","volume":"67","author":"Ayonrinde","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jhep.2021.06.045","article-title":"Maternal obesity increases the risk and severity of NAFLD in offspring","volume":"75","author":"Hagstr\u00f6m","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib21","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.04.036_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/liv.13973","article-title":"Cardiovascular risk factors in non-alcoholic fatty liver disease","volume":"39","author":"Hagstr\u00f6m","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.04.036_bib23","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.036_bib24","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.32774","article-title":"Geographical similarity and differences in the burden and genetic predisposition of NAFLD","volume":"77","author":"Yip","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/apt.17096","article-title":"Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021","volume":"56","author":"Li","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.04.036_bib28","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192013647","article-title":"Associations\u00a0of dietary-lifestyle patterns with obesity and metabolic health: two-year changes in MeDiSH(\u00ae) study cohort","volume":"19","author":"Lonnie","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jhep.2023.04.036_bib31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.04.036_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109829","article-title":"Associations of NAFLD with circulating ceramides and impaired glycemia","volume":"186","author":"Gadgil","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jhep.2023.04.036_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib34","unstructured":"United Nations. World population prospects 2022. In."},{"key":"10.1016\/j.jhep.2023.04.036_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019-2030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.04.036_bib36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib37","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-019-1171-x","article-title":"Rising rural body-mass index is the main driver of the global obesity epidemic in adults","volume":"569","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.04.036_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence,\u00a0incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","article-title":"The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with\u00a0individual and forecasting analysis, 1995-2040","volume":"15","author":"Ito","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2023.04.036_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2023.04.036_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"Hagstr\u00f6m","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2023.04.036_bib44","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/liv.15080","article-title":"The burden and sexual dimorphism with nonalcoholic fatty liver disease in Asian children: a systematic review and meta-analysis","volume":"42","author":"Zou","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.04.036_bib45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S1473-3099(16)30214-6","article-title":"Eliminating hepatitis B virus as a global health threat","volume":"16","author":"Wong","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2023.04.036_bib46","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.036_bib47","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/hep.32792","article-title":"Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta-analysis","volume":"77","author":"Mao","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib48","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/S0140-6736(18)32744-2","article-title":"Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study","volume":"393","author":"Manthey","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2023.04.036_bib49","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cgh.2018.11.033","article-title":"Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0040-1701443","article-title":"Drinking and obesity: alcoholic liver disease\/nonalcoholic fatty liver disease interactions","volume":"40","author":"\u00c5berg","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2023.04.036_bib51","unstructured":"[cited 2022-12-14]; Available from: https:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesityadult-17-18\/obesity-adult.htm."},{"key":"10.1016\/j.jhep.2023.04.036_bib52","unstructured":"CDC Obesity Data. [cited 2022-12-14]; Available from: https:\/\/www.oecdilibrary.org\/sites\/83231356-en\/index.html?itemId=\/content\/component\/83231356-en."},{"key":"10.1016\/j.jhep.2023.04.036_bib53","first-page":"404","article-title":"Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis","volume":"34","author":"Cholongitas","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jhep.2023.04.036_bib54","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jbmr.3713","article-title":"Nonalcoholic fatty liver disease in the Rotterdam study: about muscle mass, sarcopenia, fat mass, and fat distribution","volume":"34","author":"Alferink","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jhep.2023.04.036_bib55","article-title":"Characterisation of liver fat in the UK Biobank cohort","volume":"12","author":"Wilman","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.04.036_bib56","first-page":"1","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study","author":"Bj\u00f8rn\u00e5","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.04.036_bib57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.jhep.2023.04.036_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(22)00558-X","article-title":"Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019","volume":"77","author":"Nasr","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101363","article-title":"Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes","volume":"48","author":"Lembo","year":"2022","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jhep.2023.04.036_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.04.036_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062651","article-title":"Trends in the prevalence of metabolically healthy and unhealthy obesity in the US adult population: analysis of eight NHANES cross-sectional survey cycles, 1999-2014","volume":"12","author":"Wen","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhep.2023.04.036_bib62","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/ajcn\/nqab237","article-title":"Changes in adiposity among children and adolescents in the United States, 1999-2006 to 2011-2018","volume":"114","author":"Stierman","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhep.2023.04.036_bib63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","article-title":"Prevalence of nonalcoholic fatty liver disease in children with obesity","volume":"207","author":"Yu","year":"2019","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jhep.2023.04.036_bib64","first-page":"146","article-title":"Incidence of nonalcoholic fatty liver disease in children: 2009-2018","author":"Sahota","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhep.2023.04.036_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11938-022-00382-1","article-title":"Liver diseases in Latin America: current status, unmet needs, and opportunities for improvement","volume":"20","author":"D\u00edaz","year":"2022","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.036_bib66","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib67","series-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas","first-page":"157","author":"Saeedi","year":"2019"},{"key":"10.1016\/j.jhep.2023.04.036_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajg.2014.01.008","article-title":"Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: what is the prevalence and risk factors?","volume":"15","author":"Almobarak","year":"2014","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.04.036_bib69","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2023.04.036_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191388","article-title":"Steatosis in South African women: how much and why?","volume":"13","author":"Naran","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.04.036_bib71","first-page":"168","article-title":"Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis","volume":"100","author":"Kruger","year":"2010","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.jhep.2023.04.036_bib72","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(19)30179-2","article-title":"Metabolic health in the Middle East and north Africa","volume":"7","author":"Azizi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jhep.2023.04.036_bib73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.14740\/gr913w","article-title":"Non-alcoholic fatty liver disease in Africa and Middle East: an attempt to predict the present and future implications on the healthcare system","volume":"10","author":"Ahmed","year":"2017","journal-title":"Gastroenterol Res"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.036_bib74","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"Plos Med"},{"key":"10.1016\/j.jhep.2023.04.036_bib76","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.cgh.2019.04.038","article-title":"Risk factors for severe liver disease in patients with type 2 diabetes","volume":"17","author":"Bjorkstrom","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib77","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.2337\/dc23-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2023.04.036_bib78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib79","first-page":"12","article-title":"Non-alcoholic fatty liver disease in patients with polycystic ovary syndrome: a systematic review, meta-analysis, and meta-regression","author":"Manzano-Nunez","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jhep.2023.04.036_bib80","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/QAD.0000000000001504","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection","volume":"31","author":"Maurice","year":"2017","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.036_bib81","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2022.04.040","article-title":"Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease","volume":"77","author":"Staufer","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib82","first-page":"1","article-title":"Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease","author":"Hagstrom","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.04.036_bib83","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/hep.30864","article-title":"Risks of light and moderate alcohol use in fatty liver disease: follow-up of population cohorts","volume":"71","author":"\u00c5berg","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib84","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2023.04.036_bib85","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.036_bib86","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: systematic Review and Meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.04.036_bib88","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jhep.2022.03.026","article-title":"Impact of non-invasive biomarkers on hepatology practice: past, present and future","volume":"76","author":"Anstee","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib89","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.30842","article-title":"Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials","volume":"70","author":"Anstee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib90","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib91","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib92","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep4.1899","article-title":"Prevalence and risk factors of advanced liver fibrosis in a population-based study in Germany","volume":"6","author":"Huber","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2023.04.036_bib93","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.cgh.2021.12.015","article-title":"Prevalence of high and moderate risk nonalcoholic fatty liver disease among adults in the United States, 1999-2016","volume":"20","author":"Golabi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib94","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1111\/ene.15437","article-title":"Association between liver fibrosis and incident dementia in the UK Biobank study","volume":"29","author":"Parikh","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jhep.2023.04.036_bib95","article-title":"Trends and the course of liver cirrhosis and its complications in Germany: nationwide population-based study (2005 to 2018)","volume":"12","author":"Gu","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jhep.2023.04.036_bib96","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from global burden of disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib97","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib98","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib99","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/apt.14261","article-title":"Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period","volume":"46","author":"Pais","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.04.036_bib100","article-title":"NAFLD and MAFLD as emerging causes of HCC: a populational study","volume":"3","author":"Myers","year":"2021","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.036_bib101","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2021-324915","article-title":"Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database","volume":"72","author":"Vitale","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.04.036_bib102","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib103","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00535-018-1532-5","article-title":"A\u00a0nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update","volume":"54","author":"Tateishi","year":"2019","journal-title":"J\u00a0Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2023.04.036_bib104","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000333210","article-title":"Relative etiological role of prior hepatitis B virus infection and nonalcoholic\u00a0fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area","volume":"84","author":"Cho","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.jhep.2023.04.036_bib105","article-title":"Changing epidemiology of hepatocellular carcinoma in South America: a report from the South American liver research network","volume":"28","author":"Farah","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib106","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep4.1915","article-title":"Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: data from the United States Scientific Registry of Transplant Recipients","volume":"6","author":"Stepanova","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2023.04.036_bib107","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCG.0000000000000925","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in young adults in the United States","volume":"52","author":"Doycheva","year":"2018","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2023.04.036_bib108","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib109","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 annual report of the European liver transplant registry (ELTR) - 50-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2023.04.036_bib110","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/jgh.15009","article-title":"Nonalcoholic fatty liver disease burden: Australia, 2019-2030","volume":"35","author":"Adams","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib111","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijsu.2020.05.071","article-title":"Current status of liver transplantation in Asia","volume":"82s","author":"Hibi","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.jhep.2023.04.036_bib112","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5500\/wjt.v12.i9.281","article-title":"Growing challenge of post-liver transplantation non-alcoholic fatty liver disease","volume":"12","author":"Kalogirou","year":"2022","journal-title":"World J Transpl"},{"key":"10.1016\/j.jhep.2023.04.036_bib113","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"Bmj"},{"key":"10.1016\/j.jhep.2023.04.036_bib114","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","article-title":"Non-invasive tests accurately stratify patients with NAFLD\u00a0based on their risk of liver-related events","volume":"76","author":"Boursier","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib116","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.cgh.2019.10.023","article-title":"Health care costs of patients with biopsy-confirmed nonalcoholic fatty liver disease are nearly twice those of matched controls","volume":"18","author":"Hagstr\u00f6m","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib117","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib118","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.036_bib119","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.32519","article-title":"Risk of cardiovascular disease and loss in life expectancy in NAFLD","volume":"76","author":"Shang","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.036_bib120","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.04.036_bib121","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.cgh.2017.04.040","article-title":"Histologic scores for fat and fibrosis associate with development of type 2 diabetes in patients with nonalcoholic fatty liver disease","volume":"15","author":"Bj\u00f6rkstr\u00f6m","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.036_bib122","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/liv.15195","article-title":"Risk of hepatic and extrahepatic cancer in NAFLD: a population-based cohort study","volume":"42","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.04.036_bib123","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/hep.31845","article-title":"Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study","volume":"74","author":"Simon","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.04.036_bib124","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.jhep.2023.04.036_bib125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jgh3.12512","article-title":"Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"5","author":"Shengir","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.jhep.2023.04.036_bib126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a\u00a0consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib127","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/liv.15404","article-title":"Management of NAFLD in primary care settings","volume":"42","author":"Wong","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.04.036_bib128","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-021-00477-7","article-title":"Defining comprehensive models of care for NAFLD","volume":"18","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.04.036_bib129","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","article-title":"Current therapies and new developments in NASH","volume":"71","author":"Dufour","year":"2022","journal-title":"Gut"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823003240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823003240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:52:16Z","timestamp":1759175536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823003240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0168827823003240"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.04.036","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing epidemiology, global trends and implications for outcomes of NAFLD","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}